Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1228553-33-0

Post Buying Request

1228553-33-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • [(S)-2-methyl-1-((S)-2-{5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1 H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-propyl]-carbamic acid methyl ester

    Cas No: 1228553-33-0

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

1228553-33-0 Usage

Description

[(S)-2-methyl-1-((S)-2-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1 H-imidazol-2-yl-pyrrolidine-1-carbonyl)-propyl]-carbamic acid methyl ester is a complex organic compound characterized by its intricate molecular structure. It is composed of carbamic acid, methyl ester, and various functional groups, including a boron-containing group. The presence of imidazol-2-yl, pyrrolidine-1-carbonyl, and tetramethyl groups suggests that this compound may exhibit unique chemical and biological properties, making it a candidate for pharmaceutical research and other chemical applications. Its complex nature also implies that specialized synthesis and analysis techniques may be necessary for its study and application.

Uses

Used in Pharmaceutical Research:
[(S)-2-methyl-1-((S)-2-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1 H-imidazol-2-yl-pyrrolidine-1-carbonyl)-propyl]-carbamic acid methyl ester is used as a potential candidate in pharmaceutical research for its unique chemical and biological properties. [(S)-2-methyl-1-((S)-2-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1 H-imidazol-2-yl-pyrrolidine-1-carbonyl)-propyl]-carbamic acid methyl ester's structure, which includes various functional groups, may contribute to its effectiveness in targeting specific biological pathways or interactions, making it a valuable tool in the development of new drugs or therapies.
Used in Chemical Applications:
In the field of chemical applications, [(S)-2-methyl-1-((S)-2-5-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1 H-imidazol-2-yl-pyrrolidine-1-carbonyl)-propyl]-carbamic acid methyl ester may be utilized for its specific reactivity or as a component in the synthesis of other complex molecules. Its unique structure and functional groups could be harnessed to create new materials or compounds with desired properties for various industrial or research purposes.

Check Digit Verification of cas no

The CAS Registry Mumber 1228553-33-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,5,5 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1228553-33:
(9*1)+(8*2)+(7*2)+(6*8)+(5*5)+(4*5)+(3*3)+(2*3)+(1*3)=150
150 % 10 = 0
So 1228553-33-0 is a valid CAS Registry Number.

1228553-33-0Downstream Products

1228553-33-0Relevant articles and documents

5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS

-

, (2018/08/20)

Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS

-

, (2017/12/17)

A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.

NOVEL INHIBITORS OF HEPATITIS C VIRUS

-

, (2015/09/22)

The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1228553-33-0